Patent · US Active

Pyridazinyl derivatives as SMO inhibitors

US9409871B2 · kind B2 · utility

4Cited by

13References

2Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Feng He · Nanhu, CN
Stefan Peukert · Frankfurt am Main, DE
Karen Miller-Moslin · Princeton, US
Naeem Yusuff · Cambridge, US
Zhuoliang Chen · Cambridge, US
Bharat Lagu · Maywood, US

Key dates

Filing date	May 30, 2013
Grant date	Aug 9, 2016
Priority date	—
Expiry date	Dec 22, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.